Cytoskeletal active compounds, compositions and use
The present invention is directed to synthetic cytoskeletal active compounds that are related to natural Latrunculin A or Latrunculin B. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically
-
Page/Page column 21
(2010/11/23)
More Articles about upstream products of 911040-45-4